Validation of Self-Administered Single-Item Screening Questions (SISQs) for Unhealthy Alcohol and Drug Use in Primary Care Patients

Journal of General Internal Medicine

Volumn 30, Issue 12, 2015, Pages 1757-1764

  McNeely, Jennifer ^a,b,c   Cleland, Charles M ^c,d   Strauss, Shiela M ^c,d   Palamar, Joseph J ^a,c   Rotrosen, John ^a   Saitz, Richard ^e,f  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of General Internal Medicine   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f BOSTON MEDICAL CENTER   (United States)

Author keywords

Alcohol; Illicit drugs; Screening; Substance use; Validation

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG; OPIATE; PRESCRIPTION DRUG; PSYCHEDELIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DRUG MISUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE ITEM SCREENING QUESTION; SUBSTANCE ABUSE; ALCOHOLISM; CLINICAL TRIAL; FEASIBILITY STUDY; MASS SCREENING; MASSACHUSETTS; MIDDLE AGED; MULTICENTER STUDY; NEW YORK; PERSONAL DIGITAL ASSISTANT; PREVALENCE; PRIMARY HEALTH CARE; PROCEDURES; QUESTIONNAIRE; REPRODUCIBILITY; SELF REPORT; SUBSTANCE-RELATED DISORDERS; VALIDATION STUDY; YOUNG ADULT;

ADULT; AGED; ALCOHOLISM; COMPUTERS, HANDHELD; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MASSACHUSETTS; MIDDLE AGED; NEW YORK CITY; PREVALENCE; PRIMARY HEALTH CARE; REPRODUCIBILITY OF RESULTS; SELF REPORT; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84946494789     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3391-6     Document Type: Article

References (56)

1. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med. 2006;31(1):52–61.
2. Moyer VA. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. preventive services task force recommendation statement. Ann Intern Med. 2013;159(3):210–218.
3. Solberg LI, Maciosek MV, Edwards NM. Primary care intervention to reduce alcohol misuse ranking its health impact and cost effectiveness. Am J Prev Med. 2008;34(2):143–152.
4. Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(7):557–568.
5. Substance Abuse and Mental Health Services Administration (SAMHSA). About SBIRT. Available from: http://www.samhsa.gov/sbirt/about. Accessed 2015 March 30.
6. Substance Abuse and Mental Health Services Administration (SAMHSA). In: Center for Substance Abuse Treatment, ed. A guide to substance abuse services for primary care clinicians. Rockville: Substance Abuse and Mental Health Services Administration; 1997.
7. National Institute on Drug Abuse (NIDA). Screening for Drug Use in Medical Settings: National Institutes of Health; 2010. Available from: http://www.webcitation.org/6WjPYIB76. Accessed 2015 March 30.
8. Roy-Byrne P, Bumgardner K, Krupski A, Dunn C, Ries R, Donovan D, et al. Brief intervention for problem drug use in safety-net primary care settings a randomized clinical trial. JAMA-J Am Med Assoc. 2014;312(5):492–501.
9. Saitz R, Palfai TPA, Cheng DM, Alford DP, Bernstein JA, Lloyd-Travaglini CA, et al. Screening and brief intervention for drug use in primary care the ASPIRE randomized clinical trial. JAMA-J Am Med Assoc. 2014;312(5):502–513.
10. Saitz R, Alford DP, Bernstein J, Cheng DM, Samet J, Palfai T. Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed. J Addict Med. 2010;4(3):123–130.
11. U.S. Preventive Services Task Force. Screening for Illicit Drug Use: U.S. Preventive Services Task Force Recommendation Statement. 2008. Available from: http://www.webcitation.org/6WjMUXPGw. Accessed 2015 March 30.
12. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6(4):e1000058.
13. Antoniou T, Tseng AL. Interactions between recreational drugs and antiretroviral agents. Ann Pharmacother. 2002;36(10):1598–1613.
14. Lindsey WT, Stewart D, Childress D. Drug interactions between common illicit drugs and prescription therapies. Am J Drug Alcohol Abus. 2012;38(4):334–343.
15. Malta M, Strathdee SA, Magnanini MM, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242–1257.
16. Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17(5):377–381.
17. Centers for Disease Control and Prevention. Unintentional poisoning deaths–United States, 1999–2004. MMWR Morb Mortal Wkly Rep. 2007;56(5):93–96.
18. Baumeister SE, Gelberg L, Leake BD, Yacenda-Murphy J, Vahidi M, Andersen RM. Effect of a primary care based brief intervention trial among risky drug users on health-related quality of life. Drug Alcohol Depend. 2014;142:254–261. doi:10.1016/j.drugalcdep.2014.06.034.
19. Williams EC, Johnson ML, Lapham GT, Caldeiro RM, Chew L, Fletcher GS, et al. Strategies to implement alcohol screening and brief intervention in primary care settings: a structured literature review. Psychol Addict Behav: J Soc Psychol Addicti Behav. 2011;25(2):206–214.
20. Kaner E. Brief alcohol intervention: time for translational research. Addiction. 2010;105(6):960–961. discussion 4–5.
21. Nilsen P. Brief alcohol intervention–where to from here? Challenges remain for research and practice. Addiction. 2010;105(6):954–959.
22. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med. 2009;24(7):783–788.
23. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155–1160.
24. Saitz R, Cheng DM, Allensworth-Davies D, Winter MR, Smith PC. The ability of single screening questions for unhealthy alcohol and other drug use to identify substance dependence in primary care. J Stud Alcohol Drugs. 2014;75(1):153–157.
25. Bradley KA, Lapham GT, Hawkins EJ, Achtmeyer CE, Williams EC, Thomas RM, et al. Quality concerns with routine alcohol screening in VA clinical settings. J Gen Intern Med. 2011;26(3):299–306.
26. Williams EC, Achtmeyer CE, Thomas RM, Grossbard JR, Lapham GT, Chavez LJ, et al. Factors underlying quality problems with alcohol screening prompted by a clinical reminder in primary care: A multi-site qualitative study. J Gen Intern Med. 2015 doi:10.1007/s11606-015-3248-z
27. Johnson M, Jackson R, Guillaume L, Meier P, Goyder E. Barriers and facilitators to implementing screening and brief intervention for alcohol misuse: a systematic review of qualitative evidence. J Publ Health (Oxf). 2011;33(3):412–421.
28. Sterling S, Kline-Simon AH, Wibbelsman C, Wong A, Weisner C. Screening for adolescent alcohol and drug use in pediatric health-care settings: predictors and implications for practice and policy. Addict Sci Clin Pract. 2012;7(1):13.
29. Spear SS, M, Gilberti B, Fiellin M, McNeely J. Usability and acceptability of an audio guided computer-assisted self-interview (ACASI) version of the Alcohol, Smoking, and Substance Involvement Screening Test. Presented at Addiction Health Services Research Conference 2013.
30. Tourangeau R, Smith TW. Asking sensitive questions - the impact of data collection mode, question format, and question context. Publ Opin Q. 1996;60(2):275–304.
31. Wight RG, Rotheram-Borus MJ, Klosinski L, Ramos B, Calabro M, Smith R. Screening for transmission behaviors among HIV-infected adults. Aids Educ Prev. 2000;12(5):431–441.
32. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013 NSDUH Series H-46, HHS Publication No.(SMA) 13–4795.
33. Lee JD, Delbanco B, Wu E, Gourevitch MN. Substance use prevalence and screening instrument comparisons in urban primary care. Subst Abus: Off Publ Assoc Med Educ Res Subst Abus. 2011;32(3):128–134.
34. Arozullah AM, Yarnold PR, Bennett CL, Soltysik RC, Wolf MS, Ferreira RM, et al. Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care. 2007;45(11):1026–1033.
35. Alonzo TA, Pepe MS. Using a combination of reference tests to assess the accuracy of a new diagnostic test. Stat Med. 1999;18(22):2987–3003.
36. Sobell LC, Sobell MB. Timeline follow-back. Measuring alcohol consumption. New York: Springer; 1992:41–72.
37. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Helping patients who drink too much: a clinician’s guide, 2005 ed.: NIAAA; 2007. Available from: http://pubs.niaaa.nih.gov/publications/Practitioner/CliniciansGuide2005/guide.pdf. Accessed 2015 March 30.
38. Cooke F, Bullen C, Whittaker R, McRobbie H, Chen MH, Walker N. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res: Off J Soc Res Nicotine Tob. 2008;10(4):607–612.
39. Heltsley R, DePriest A, Black DL, Robert T, Marshall L, Meadors VM, et al. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. J Anal Toxicol. 2011;35(8):529–540.
40. Cone EJ, Presley L, Lehrer M, Seiter W, Smith M, Kardos KW, et al. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J Anal Toxicol. 2002;26(8):541–546.
41. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Harnett Sheehan K, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatr. 1997;12(5):224–231.
42. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatr. 1998;59(Suppl 20):22–33. quiz 4–57.
43. Allensworth-Davies D, Cheng DM, Smith PC, Samet JH, Saitz R. The Short Inventory of Problems-Modified for Drug Use (SIP-DU): validity in a primary care sample. Am J Addict/Am Acad Psychiatr Alcohol Addict. 2012;21(3):257–262.
44. Feinn R, Tennen H, Kranzler HR. Psychometric properties of the short index of problems as a measure of recent alcohol-related problems. Alcohol Clin Exp Res. 2003;27(9):1436–1441.
45. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44(8):763–770.
46. Satre D, Wolfe W, Eisendrath S, Weisner C. Computerized screening for alcohol and drug use among adults seeking outpatient psychiatric services. Psychiatr Serv. 2008;59(4):441–444.
47. Butler SFCE, Bromberg JI, Budman SH, Buono DP. Computer-assisted screening and intervention for alcohol problems in primary care. J Technol Hum Serv. 2003;21(3):1–19.
48. Reichmann WM, Losina E, Seage GR, Arbelaez C, Safren SA, Katz JN, et al. Does modality of survey administration impact data quality: audio computer assisted self interview (ACASI) versus self-administered pen and paper? PLoS One. 2010;5(1):e8728.
49. Seed P. DIAGT: Stata module to report summary statistics for diagnostic tests compared to true disease status 2010. Available from: http://EconPapers.repec.org/RePEc:boc:bocode:s423401. Accessed 2015 March 30.
50. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36.
51. Newman JC, Des Jarlais DC, Turner CF, Gribble J, Cooley P, Paone D. The differential effects of face-to-face and computer interview modes. Am J Public Health. 2002;92(2):294–297.
52. Rogers SM, Willis G, Al-Tayyib A, Villarroel MA, Turner CF, Ganapathi L, et al. Audio computer assisted interviewing to measure HIV risk behaviours in a clinic population. Sex Transm Infect. 2005;81(6):501–507.
53. Turner CF, Al-Tayyib A, Rogers SM, Eggleston E, Villarroel MA, Roman AM, et al. Improving epidemiological surveys of sexual behaviour conducted by telephone. Int J Epidemiol. 2009;38(4):1118–1127.
54. Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res. 2007;31(2):185–199.
55. Bradley KA, Bush KR, Epler AJ, Dobie DJ, Davis TM, Sporleder JL, et al. Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med. 2003;163(7):821–829.
56. Grekin ER, Svikis DS, Lam P, Connors V, Lebreton JM, Streiner DL, et al. Drug use during pregnancy: validating the Drug Abuse Screening Test against physiological measures. Psychol Addict Behav: J Soc Psychol Addict Behav. 2010;24(4):719–723.